Gene Delivery Technologies Market By Delivery Type (Viral, Non-Viral); By Application (Gene Therapy, Vaccinology, Genetic Engineering, Biomedical Research); By End User (Biopharmaceutical Companies, Academic & Research Institutes, CROs, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Gene Delivery Technologies Market will witness a robust CAGR of 13.4%, valued at $4.7 billion in 2024, and is expected to appreciate and reach $11.2 billion by 2030, confirms Strategic Market Resea... Read More

Cartilage Repair Market By Procedure Type (Cell-Based [Autologous Chondrocyte Implantation, Stem Cell Therapy, Growth Factor Therapy], Non-Cell-Based [Microfracture, Osteochondral Grafting, Chondroplasty, Scaffolds]); By Application (Knee, Hip, Ankle & Foot, Shoulder & Elbow); By End User (Hospitals & Clinics, ASCs, Sports Medicine Centers, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Cartilage Repair Market Report Introduction and Strategic Context

The Global Cartilage Repair Market will witness a robust CAGR of 8.7%, valued at $3.42 billion in 2024, and is expected to appreciate and reach $5.63 billion by 2030, confirms Strategic Market Research.... Read More

Hernia Mesh Devices Market By Product Type (Synthetic Mesh, Biologic Mesh, Composite Mesh); By Surgery Type (Open Repair, Laparoscopic Repair, Robotic-Assisted Repair); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

As of 2024, the global hernia mesh devices market is estimated at USD 4.8 billion and is projected to reach approximately USD 7.5 billion by 2030, growing at a CAGR of 7.7% during the forecast period. This growth is fueled by a stead... Read More

Neuroendovascular Coil Market By Product Type (Bare Platinum Coils, Hydrogel Coated Coils, Bioactive Coils, Other Advanced Coils); By Application (Intracranial Aneurysm, Arteriovenous Malformations, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation & Forecast, 2024–2030

Introduction and Strategic Context

The global neuroendovascular coil market represents a critical segment of the minimally invasive neur... Read More

Intermittent Catheters Market By Product Type (Hydrophilic Coated, Non-Hydrophilic, Pre-lubricated, Reusable); By Application (Neurogenic Bladder, Non-Neurogenic Bladder, Others); By End User (Hospitals & Clinics, Homecare Settings, Long-Term Care Facilities, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The global intermittent catheters market is gaining strategic importance as healthcare systems worldwide priorit... Read More

Smoking Cessation and Nicotine De-addiction Market By Product Type (E-Cigarettes, Nicotine Replacement Therapy [Patch, Gum, Inhaler, Nasal Spray, Lozenges], Drug Therapy [Varenicline, Bupropion]); By Route of Administration (Oral, Nasal, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Smoking Cessation and Nicotine De-addiction Market is projected to grow from $23.8 billion in 2024 to $42.2 billion by 2030, registering a CAGR of 10.1% during the forecast period. Rising health awareness and government initiatives to curb tobacco use are driving growth in the smoking ... Read More

Hyperphosphatemia Market By Product Type (Calcium-Based Phosphate Binders, Non-Calcium-Based Phosphate Binders, Others); By Indication (Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD), Acute Kidney Injury (AKI), Others); By End User (Hospitals, Dialysis Centers, Specialty Clinics, Homecare Settings, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Hyperphosphatemia Market is projected to grow from $4.3 billion in 2024 to $5.7 billion by 2030, registering a CAGR of 4.8% during the forecast period. The market growth is fueled by the growing global dialysis population, increasing CKD awareness, and expanding reimbursement for novel... Read More

In-Silico Drug Discovery Market By Workflow (Preclinical, Clinical, Discovery); By Therapeutic Area (Oncology, Central Nervous System (CNS), Infectious Disease, Cardiovascular); By End User (CROs, Pharma & Biotech, Academic Institutes, Government/Non-Profit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global In-Silico Drug Discovery Market is projected to grow from $3.6 billion in 2024 to $6.8 billion by 2030, registering a CAGR of 11.2% during the forecast period. This surge is underpinned by the rising adoption of AI-led platforms, increasing pharmaceutical R&D digitization, and the ... Read More

Epigenetics Market By Product (Reagents, Instruments, Software & Services); By Technology (DNA Methylation, Histone Modification, RNA Associated Silencing, Others); By Application (Cancer Research, Age-related Diseases, Precision Medicine, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Epigenetics Market is projected to grow from $2.3 billion in 2024 to $5.1 billion by 2030, registering a CAGR of 13.4% during the forecast period. Epigenetics examines heritable and stable modifications in gene expression that result from changes in the chromosome rather than alteratio... Read More

Natural Killer (NK) Cell Therapeutics Market By Therapeutic Type (NK Cell Engagers, CAR-NK Cell Therapy, NK Cell Therapy [Unmodified]); By Indication (Cancer, Immunoproliferative Disorders, Gastrointestinal Diseases, Others); By End User (Hospitals, Research Centers & Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Natural Killer (NK) Cell Therapeutics Market is projected to grow from $1.6 billion in 2024 to $3.9 billion by 2030, registering a CAGR of 17.3% during the forecast period. Natural killer (NK) cells are a type of innate lymphoid cell that targets and eliminates infected or diseased cel... Read More